Addressing the risks of antidepressants among people with alcohol use disorders.
作者信息
Wood Evan, Rehm Jürgen
机构信息
Professor of Medicine, University of British Columbia, Vancouver, BC.
Senior Scientist, Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ont.
出版信息
CMAJ. 2024 Mar 17;196(10):E349-E350. doi: 10.1503/cmaj.150095-l.
Abstract
摘要
相似文献
1
Addressing the risks of antidepressants among people with alcohol use disorders.
CMAJ. 2024 Mar 17;196(10):E349-E350. doi: 10.1503/cmaj.150095-l.
2
Antidepressant treatment of co-occurring depression and alcohol dependence.
Biol Psychiatry. 2004 Nov 15;56(10):785-92. doi: 10.1016/j.biopsych.2004.07.016.
3
Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008581. doi: 10.1002/14651858.CD008581.pub2.
4
Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
J Clin Psychiatry. 2011 Aug;72(8):1144-51. doi: 10.4088/JCP.10m06217. Epub 2011 Apr 19.
5
Antidepressants in elderly people.
BMJ. 2011 Aug 2;343:d4660. doi: 10.1136/bmj.d4660.
6
[Antidepressants in the treatment of alcoholism].
Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(5 Pt 2):32-5.
7
New indications for antidepressants.
J Clin Psychiatry. 2000;61 Suppl 11:9-17.
8
Blood level monitoring of antipsychotics and antidepressants.
Psychiatr Med. 1991;9(1):163-87.
9
[Evolution of benefit-risk ratio of antidepressants].
Therapie. 1995 Nov-Dec;50(6):515-21.
10
New antidepressants and trends in the pharmacotherapy of depressive disorders.
Psychiatr Clin North Am. 1983 Mar;6(1):129-39.
引用本文的文献
1
Rethinking trazodone for insomnia in alcohol use disorder.
Addict Sci Clin Pract. 2025 Mar 25;20(1):30. doi: 10.1186/s13722-025-00552-3.
2
Species differences in comorbid alcohol use disorder and major depressive disorder: A narrative review.
Alcohol Clin Exp Res (Hoboken). 2025 Apr;49(4):712-724. doi: 10.1111/acer.70015. Epub 2025 Mar 9.
3
Correction to "Addressing the risks of antidepressants among people with alcohol use disorders".
CMAJ. 2024 Jul 14;196(25):E884. doi: 10.1503/cmaj.240910.
本文引用的文献
1
Navigating the nuances of the Canadian guideline's stance on selective serotonin reuptake inhibitors in concurrent alcohol use disorder and mood or anxiety disorders.
CMAJ. 2024 Mar 17;196(10):E348. doi: 10.1503/cmaj.150034-l.
2
Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder.
CMAJ. 2024 Mar 17;196(10):E346-E347. doi: 10.1503/cmaj.149917-l.
3
Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder.
CMAJ. 2023 Oct 16;195(40):E1364-E1379. doi: 10.1503/cmaj.230715.
4
Pharmacological Treatment of Mood Disorders and Comorbid Addictions: A Systematic Review and Meta-Analysis: Traitement Pharmacologique des Troubles de L'humeur et des Dépendances Comorbides: Une Revue Systématique et une Méta-Analyse.
Can J Psychiatry. 2020 Nov;65(11):749-769. doi: 10.1177/0706743720915420. Epub 2020 Apr 17.
5
Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008581. doi: 10.1002/14651858.CD008581.pub2.
6
Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.
Alcohol Clin Exp Res. 2015 Sep;39(9):1756-65. doi: 10.1111/acer.12802. Epub 2015 Jul 24.
7
Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD007505. doi: 10.1002/14651858.CD007505.pub2.
8
A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.
J Clin Psychopharmacol. 2011 Feb;31(1):22-30. doi: 10.1097/JCP.0b013e31820465fa.
9
Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial.
Alcohol Clin Exp Res. 2008 Sep;32(9):1652-60. doi: 10.1111/j.1530-0277.2008.00742.x. Epub 2008 Jul 8.
10
Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology.
Drug Alcohol Depend. 2004 Apr 9;74(1):61-70. doi: 10.1016/j.drugalcdep.2003.11.012.
Zotero 插件